- Uncategorized
-
Module 1: Renal Basics
-
- Quiz
-
- Quiz
-
-
Module 2: Types of Dialysis
-
- Quiz
-
- Quiz
-
- Quiz
-
-
Module 3: Dialysis Machine Features
-
- Quiz
-
- Quiz
-
- Quiz
-
-
Module 4: Sales Strategies
-
- Quiz
-
- Quiz
-
-
others
CRRT (Continuous Renal Replacement Therapy)
Continuous Renal Replacement Therapy (CRRT) – Key Information for Sales Teams
1. What is CRRT?
Definition: A slow, continuous blood purification therapy used in critically ill ICU patients who cannot tolerate traditional hemodialysis.
Used for:
Acute Kidney Injury (AKI) with hemodynamic instability (low BP).
Sepsis with multi-organ failure.
Fluid overload (e.g., heart failure, ARDS).
2. How CRRT Differs from Standard Hemodialysis (HD)
Feature | CRRT | Standard HD |
---|---|---|
Speed | Slow (24/7) | Fast (3-4 hrs/session) |
BP Stability | Better for unstable patients | Risk of hypotension |
Solute Removal | Continuous, gentle | Rapid, intermittent |
ICU Use | Yes | Rarely |
3. Types of CRRT
CVVH (Continuous Veno-Venous Hemofiltration)
Removes fluid + toxins via convection.
Best for fluid overload.
CVVHD (Continuous Veno-Venous Hemodialysis)
Uses diffusion (like HD).
Better for toxin removal.
CVVHDF (Continuous Veno-Venous Hemodiafiltration)
Combines CVVH + CVVHD.
Most efficient for severe AKI/sepsis.
4. Why CRRT Machines Matter for Sales
High-value ICU equipment (hospitals pay premium prices).
Key features to highlight:
Precision fluid control (avoiding sudden BP drops).
Anticoagulation management (heparin-free options).
Ease of use (touchscreen, auto-priming).
Compatibility with ECMO (for critical care synergy).
5. Common Sales Objections & Responses
❌ "Too expensive!"
→ "CRRT reduces ICU stay costs by [X]% compared to intermittent HD."
❌ "Our nurses aren’t trained!"
→ *"We provide free onsite training and 24/7 support."*
❌ "We already have HD machines."
→ "CRRT is for unstable patients—HD can’t replace it in ICU."
YouTube Tutorials on CRRT
📺 CRRT Explained – ICU Advantage
📺 CRRT Machine Demo – [Your Brand’s Training Video]
There are no comments for now.